~~<i id='9AFFC955C7'><strike id='9AFFC955C7'><tt id='9AFFC955C7'><pre id='9AFFC955C7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：entertainment 2025-08-31 20:56:19 - browse：13

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Reports of telehealth's death have been greatly exaggerated

leisure time

entertainment

hotspot

knowledge

AdobeTheFoodandDrugAdministrationispoisedtotelldrugandmedicaldevicemakershowtobetterincludepeopleofc

WSS

When prostate cancer spreads, where it goes matters

Scrutiny of post

FDA poised to publish guidelines for clinical trial diversity

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

For longer

Bird flu: Don't repeat Covid's 'health versus the economy' framing

focus

Wikipedia

leisure time

Affirmative action in medical school literally saved lives

Case highlights the risks of experimental stem cell therapy

Moonlake's readout produced a cash windfall. Risks remain

As a primary care physician, here's how I hope to partner with AI

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: More tumult at BIO & coercive care for sickle cell patients

Peter Hotez and the public health issue of online harassment

When prostate cancer spreads, where it goes matters

Bright Health sells Medicare Advantage business to Molina

Anxious about a speech? A startup wants you to pop a minty cardiac drug

entertainment

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Liver decline slowed by off

Citing H5N1 threat, CDC urges peak flu monitoring this summer

For longer

Wearables generate powerful data but its not useful to doctors, yet

HIV vaccine remains elusive. Immunologists keep trying new ideas

hotspot

hotspot

knowledge

knowledge